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Abstract
Cleaning and disinfecting products consisting of a mixture of hydrogen peroxide (HP), peracetic 
acid (PAA), and acetic acid (AA) are widely used as sporicidal agents in health care, childcare, 
agricultural, food service, and food production industries. HP and PAA are strong oxidants and 
their mixture is a recognized asthmagen. However, few exposure assessment studies to date have 
measured HP, PAA, and AA in a health care setting. In 2015, we performed a health and exposure 
assessment at a hospital where a new sporicidal product, consisting of HP, PAA, and AA was 
introduced 16 months prior. We collected 49 full-shift time-weighted average (TWA) air samples 
and analyzed samples for HP, AA, and PAA content. Study participants were observed while they 
performed cleaning duties, and duration and frequency of cleaning product use was recorded. 
Acute upper airway, eye, and lower airway symptoms were recorded in a post-shift survey (n = 
50). A subset of 35 cleaning staff also completed an extended questionnaire that assessed 
symptoms reported by workers as regularly occurring or as having occurred in the previous 12 
months. Air samples for HP (range: 5.5 to 511.4 ppb) and AA (range: 6.7 to 530.3 ppb) were all 
below established US occupational exposure limits (OEL). To date, no full-shift TWA OEL for 
PAA has been established in the United States, however an OEL of 0.2 ppm has been suggested by 
several research groups. Air samples for PAA ranged from 1.1 to 48.0 ppb and were well below 
the suggested OEL of 0.2 ppm. Hospital cleaning staff using a sporicidal product containing HP, 
PAA, and AA reported work-shift eye (44%), upper airway (58%), and lower airway (34%) 
symptoms. Acute nasal and eye irritation were significantly positively associated with increased 
exposure to the mixture of the two oxidants: HP and PAA, as well as the total mixture (TM) of HP, 
PAA, and AA. Shortness of breath when hurrying on level ground or walking up a slight hill was 
significantly associated with increased exposure to the oxidant mixture (P = 0.017), as well as the 
TM (P = 0.026). Our results suggest that exposure to a product containing HP, PAA, and AA 
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contributed to eye and respiratory symptoms reported by hospital cleaning staff at low levels of 
measured exposure.
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Introduction
Cleaning and disinfectant products are widely used in health care settings to minimize health 
care-acquired infections (HAIs). HAIs are estimated to cost the US health care industry 
$8.5–11.3 billion annually (Zimlichman et al., 2013). The high costs associated with HAIs 
have increased demand for effective cleaning and disinfection products that can reduce 
infectious bacteria like methicillin-resistant Staphylococcus aureus, vancomycin-resistant 
Enterococcus, and Clostridium difficile (C. diff) in health care environments (Weber et al., 
2010). C. diff alone is estimated to cause ~15 000 deaths and cost the health care industry ~
$1–5 billion annually (Dubberke and Olsen, 2012; CDC, 2016). Because C. diff spores are 
highly resistant to many chemical and physical agents and can persist on hospital surfaces 
for months, health care cleaning and disinfecting practices often rely on chemicals with 
sporicidal activity to attain disinfection (Weber et al., 2010). Glutaraldehyde, formaldehyde, 
chlorine compounds, hydrogen peroxide (HP), and peroxy acids are known to have 
sporicidal activity; however, inhalational exposure to each of these chemical agents may 
contribute to adverse health outcomes such as upper airway irritation and irritant or 
sensitizer induced asthma (Russell, 1990; Rideout et al., 2005; AOEC, 2015). Of the 
chemicals with sporicidal activity, glutaraldehyde, formaldehyde, and peroxy acids are 
typically used for sterilization of medical equipment. Sporicidal mixtures composed of 
chlorine compounds, and mixtures of HP and peroxy acids, are often used in areas 
throughout a health care facility as surface cleaners and disinfectants (Russell, 1990; Weber 
et al., 2010; Abreu et al., 2013). Cleaning and disinfecting products containing a mixture of 
HP, peracetic acid (PAA), and acetic acid (AA) are currently widely used as surface cleaners 
and sterilants in hospitals and are promoted as a safer alternative to chemical sterilants like 
glutaraldehyde and formaldehyde; however, there are few studies to support these claims 
(Rideout et al., 2005).
Previous studies observed an increased risk for dermatitis, chronic bronchitis, and work-
related rhinitis and asthma in workers exposed to cleaning and disinfectant chemicals in 
many different occupational settings (Rosenman et al., 2003; Medina-Ramón et al., 2005; 
Maçãira et al., 2007; Arif et al., 2009; Charles et al., 2009; Vizcaya et al., 2011; Arif and 
Delclos, 2012; Dumas et al., 2012; Folletti et al., 2014). Exposure to cleaning products has 
been associated with work-related asthma in agriculture, construction, manufacturing, 
transportation, whole sale, retail trade, services, and government industries (Rosenman et al., 
2003). Although respiratory effects have been well documented in workers exposed to 
cleaning and disinfecting products, few previous studies have simultaneously evaluated (i) 
cleaning workers’ full-shift personal exposures to cleaning and disinfectant chemicals and 
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(ii) upper and lower airway symptoms reported as having occurred during the workers’ shift. 
Additionally, despite widespread use of products containing a mixture of HP, PAA, and AA, 
few assessments of hospital cleaning workers’ exposure to HP, PAA, and AA have been 
performed to date.
In 2015, the National Institute for Occupational Safety and Health (NIOSH) conducted a 
health hazard evaluation at a hospital where a new sporicidal product (Product A), consisting 
of HP, PAA, and AA, was introduced in the previous year to aid in the control of health 
care–associated infections. The product was used as a one-step disinfectant and sporicidal 
agent on all surfaces throughout the hospital, except floors. Hospital cleaning staff cited 
concerns about exposure to Product A, and occurrence of symptoms related to product use 
that included eye and nasal problems, asthma-like symptoms, shortness of breath, wheeze, 
chest tightness, and cough. We collected personal, time-weighted average (TWA) air 
samples for HP, PAA, and AA on participants while they performed their regular cleaning 
duties, and administered a post-shift survey to evaluate acute upper and lower airway 
symptoms that occurred across their work shifts. Some participants also completed an 
extended questionnaire that assessed symptoms reported as regularly occurring or as having 
occurred in the previous 12 months. To our knowledge, no previous studies have assessed 
acute (cross-shift) and chronic upper and lower airway symptoms in hospital cleaning staff 
exposed to a mixture of HP, PAA, and AA.
Methods
Study population
Hospital cleaning staff on all three shifts, and in all hospital departments, were invited to 
participate in the air sampling, post-shift survey, and extended questionnaire. Participation 
was voluntary. Workers gave informed consent before participating in the air sampling, post-
shift survey, and extended questionnaire. Demographic information was collected in the 
extended questionnaire.
Exposure assessment
We collected 50 TWA, full-shift samples while participants performed their regular cleaning 
duties throughout the hospital. Full-shift samples of 41 participants were collected from 
workers’ breathing zones while eight samples were mobile-area samples. For the mobile-
area samples, we followed participants while they performed their cleaning duties and 
placed the samplers near the participants in the rooms while they cleaned. TWA samples 
were collected from participants assigned to the following hospital areas: main operating 
rooms, birth center, birth center triage, birth center operating room, ante- and post-partum, 
medical-surgical, orthopedic surgery, intensive care unit, oncology, neonatal intensive care 
unit, outpatient clinic, and public bathrooms. Four samples were collected from ‘float’ 
cleaning employees who were assigned to cover regular cleaning duties in multiple areas of 
the hospital. One sample was collected on an employee assigned to clean floors in multiple 
areas of the hospital and who did not use Product A during their cleaning duties.
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All air samples were analyzed for HP, PAA, and AA content. HP and PAA were 
simultaneously collected on a cassette in-line with a glass tube sampler at a flow rate of 1 
liter per minute (lpm), and were analyzed according to the method specified by Hecht et al. 
(2004). HP was collected on two quartz filters coated with titanium oxysulfate hydrate 
preloaded in a 25 millimeter (mm) two-piece polystyrene cassette with no support pad (SKC 
2016). PAA was collected on a glass tube containing 800 mg silica gel coated with methyl p-
tolylsulfoxide with two glass wool separators, downstream of the HP quartz filters (SKC 
2016). AA was collected using glass sampling tubes containing coconut shell charcoal at a 
flow rate of 0.2 lpm and analyzed according to Occupational Safety and Health 
Administration (OSHA) Method PV2119 [OSHA 2003].
We also observed participants while they performed their regular cleaning duties and 
recorded task duration, cleaning products used, duration of cleaning product use, and use of 
any personal protective equipment. In addition to Product A, participants also used other 
products that contained asthmagens including ethanolamine, bleach, and quaternary 
ammonium compounds. Use of other asthmagen-containing products was summed to create 
an asthmagen score to account for use of all other asthmagen-containing products. Other 
asthmagen-containing products were defined as products that contained chemicals listed as 
an asthmagen by the AOEC (AOEC 2015). A summed asthmagen score of 0 to 3 was 
assigned to evaluate use of all other asthmagen products by workers during their regular 
cleaning duties. A minimum score of zero indicated that a participant did not use any 
products containing ethanolamines, bleach, or quaternary ammonium compounds during 
their shift whereas a maximum score of three indicated a participant used products 
containing ethanolamines, bleach, and quaternary ammonium compounds during their shift.
Post-shift survey of acute symptoms
We administered a voluntary post-shift survey to workers (n = 50) who participated in the air 
sampling survey. The post-shift survey asked if participants had experienced eye, upper 
airway, or lower airway symptoms during their shift. When workers reported symptoms that 
occurred during their work shift, we asked (i) if their symptom had worsened during their 
shift; (ii) what they were doing when the symptom first began; and (iii) if they had that 
symptom upon arrival at work that day. We focused our analyses on work-related symptoms, 
which were defined as symptoms that occurred during the participants’ shift that were not 
present upon arrival at work that day. Participants were asked about the following 
symptoms: burning, itchy, runny nose; sneeze; burning, itchy, watery eyes; burning, dry, sore 
throat; cough; wheeze; chest tightness; shortness of breath; difficulty breathing; and 
dizziness. Upper airway symptoms were defined as nasal, eye, and throat symptoms. Lower 
airway symptoms were defined as cough, wheeze, chest tightness, shortness of breath, and 
difficulty breathing.
Extended questionnaire
As part of the health hazard evaluation, we administered a questionnaire to 79 cleaning 
workers 1 week prior to the air sampling survey, which included 35 air sampling and post-
shift survey participants from the present study group. Questions addressed respiratory and 
dermatological symptoms, asthma and other diagnoses, smoking history, work history and 
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practices, and demographic information. Respiratory symptom and asthma questions were 
taken from the Third National Health and Nutrition Examination Survey (NHANES III) 
(Department of Health and Human Services, 1996) and the European Community 
Respiratory Health Survey (Grassi et al., 2003).
Asthma-like symptoms were defined as having responded ‘yes’ to any of the following 
questions: (i) ‘Are you currently taking any medicine (including inhalers, aerosols or tablets) 
for asthma?’ (ii) ‘Have you had wheezing or whistling in your chest at any time in the last 
12 months?’ (iii) ‘Have you woken up with a feeling of tightness in your chest at any time in 
the last 12 months?’ (iv) ‘Have you been woken by an attack of asthma at any time in the 
last 12 months?’
Statistical analyses
We used the American Conference of Governmental Industrial Hygienists (ACGIH) 
Additive Mixture Formula to create mixture exposure groups for the total mixture (TM) of 
HP, PAA, and AA as well as the oxidant exposure mixture (OM) of HP and PAA (ACGIH 
2016). Measured parts per million (ppm) concentrations of HP and AA were divided by their 
established OSHA permissible exposure limit (PEL) and NIOSH recommended exposure 
limit (REL) of 1 ppm and 10 ppm, respectively [equations (1) and (2)]. Measured ppm 
concentrations of PAA were divided by the occupational exposure limit (OEL) proposed by 
multiple researchers, of 0.2 ppm (Gagnaire et al., 2002; Pacenti et al., 2010; Pechacek et al., 
2015). TM and OM exposure was determined using equations (1) and (2),
(1)
(2)
where [HP], [PAA], and [AA] represent the measured full-shift TWA concentrations for HP, 
PAA, and AA. ACGIH states that when two or more chemicals have been observed to have 
similar toxicity on the same target organ or system, the mixture formula can be used to 
assess if an exposure exceeds the threshold limit of the mixture, which is defined as one 
(ACGIH, 2016). The summed values from the additive formula were divided into tertiles to 
create TM and OM exposure variables with low, medium, and high exposure categories. TM 
exposure was analyzed as continuous or categorical, with categories defined as (1) low = 
<0.088, (2) medium = 0.088 to 0.236, or (3) high = >0.236. OM exposure was analyzed as 
continuous or categorical with categories defined as (1) low = <0.08, (2) medium = 0.080 to 
0.218, and (3) high = >0.218. TM and OM exposure variables were used for exposure and 
health outcome analyses.
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Statistical analyses were conducted using SAS software version 9.3 (SAS Institute, Inc., 
Cary, NC). An alpha of 0.05 was used to establish significance for all hypothesis testing. 
SAS PROC GENMOD’s log-binomial regression was used to calculate prevalence ratios and 
95% confidence intervals for acute and chronic symptoms in relation to mixture exposure 
variables. When the GENMOD models did not converge, Fischer’s exact test was used to 
compare symptom prevalence among the exposure categories. Age, gender, and smoking 
status were initially included in the GENMOD log-binomial regression models, however, the 
models did not converge. The LOGISTIC procedure in SAS was used to examine 
associations of age, gender, or smoking status with upper and lower airway symptoms. The 
LOGISTIC procedure in SAS was also used to analyze associations between asthmagen 
product use, each individual chemical constituent in the TM (HP, PAA, or AA), and upper 
and lower airway symptoms in the 50 post-shift survey and 35 extended questionnaire 
participants.
Results
Exposure assessment
Overall, full-shift TWA exposure levels for HP, PAA, and AA ranged from 5.5 to 511.4 parts 
per billion (ppb), 1.1 to 48.0 ppb, and 6.7 to 530.3 ppb, respectively (Fig. 1). No samples 
were below their respective limits of detection. The limits of detection were 4 μg of HP, 2 μg 
of PAA, and 3 μg of AA per sample, respectively. One TWA full-shift sample could not be 
analyzed because of error in sampling time duration. The arithmetic mean, geometric mean, 
and 95th percentile for full-shift TWA exposure to HP, PAA, AA, and total summed ppb 
exposures for each hospital area are reported in Table 1. The highest HP, PAA, AA, OM (HP 
+ PAA), and TM (HP + PAA + AA) exposures were observed in the birth center, birth center 
triage, birth center operating rooms, and the medical-surgical areas.
Product A was the main cleaning product used for all surfaces except floors. Participants 
dispensed Product A into a bottle that they then used to pour the product into a container 
with submerged disposable wipes. All surface cleaning tasks were performed using Product 
A saturated wipes. Participants occasionally used other cleaning products containing 
ethanolamines (n = 3/50), bleach (n = 2/50), or quaternary ammonium compounds (n = 
16/50) when cleaning glass, general surfaces, or bathroom surfaces, respectively. Nitrile 
gloves were used routinely when working with cleaning products. Staff occasionally chose 
to also wear goggles when working with cleaning products. We also observed cleaning staff 
who chose to wear a surgical mask when working with cleaning products; we informed them 
that a surgical mask does not mitigate exposure to cleaning chemical vapors.
Air sampling, acute symptom survey, and extended questionnaire participants
Demographic information for cleaning staff who participated in the air sampling, post-shift 
survey, and extended questionnaire can be seen in Supplementary Table 1 (available at 
Annals of Work Exposures and Health online). The median age of participants was 40 years 
and ranged from 20 to 67 years (Supplementary Table S1, available at Annals of Work 
Exposures and Health online). Fifty-seven percent were female (Supplementary Table S1, 
available at Annals of Work Exposures and Health online). Median tenure was 3.5 years and 
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ranged from 0.21 to 26.2 years. Current, former, and never smokers accounted for 23%, 6%, 
and 71% of participants, respectively.
Work-related acute upper and lower airway symptoms
Prevalence of work-related acute eye and upper and lower airway symptoms among all post-
shift survey participants is reported in Table 2. Work-related nasal and eye irritation were the 
most commonly reported acute symptoms. Approximately half of participants reported 
work-related nasal (52%) and eye irritation (44%) (Table 2). Sneeze and burning, dry, or 
sore throat were reported by 22% and 18% of post-shift survey participants, respectively.
Symptom prevalence in low, medium, and high TM and OM exposure groups can be seen in 
Table 2. Work-related nasal irritation, eye irritation, sneeze, and burning, dry or sore throat 
was reported by 25%, 12.5%, 12.5%, and 12.5%, respectively, of participants in the lowest 
TM exposure group. The same eye and upper airway symptoms were reported by 1.4–6.5 
fold more participants in the highest TM exposure group (87.5%, 81.3%, 37.5%, and 25.0%, 
respectively). Prevalence of work-related acute eye and upper airway symptoms were similar 
in the TM and OM exposure groups (Table 2). No workers in the lowest TM or OM 
exposure groups reported acute work-related wheeze, chest tightness, shortness of breath, or 
difficulty breathing. In comparison, workers exposed to mixture levels in the medium and 
highest TM and OM exposure groups (n = 33) reported wheeze (n = 3, 9%), chest tightness 
(n = 2, 6%), shortness of breath (n = 3, 9%), and difficulty breathing (n = 2, 6%) (Table 2). 
Despite these trends, Fisher’s exact test did not indicate any significant associations.
Age, smoking status, gender, and use of other cleaning products containing asthmagens were 
not significantly associated with acute eye, upper airway, or lower airway symptoms 
reported in the post-shift survey and were not included in multiple regression models. No 
single individual chemical constituent in the TM of HP, PAA, and AA was consistently 
associated with work-related acute symptoms (Supplementary Table 2, available at Annals 
of Work Exposures and Health online). Work-related nasal and eye irritation were 
significantly positively associated with increased exposure to the TM as well as the OM. 
Both the highest TM and OM exposure groups had 3.5 (P = 0.005) fold higher prevalence of 
nasal irritation symptoms when compared to the lowest TM and OM exposure groups (Fig. 2 
and Table 3). Eye irritation prevalence was similar for both the highest TM and OM 
exposure groups as well, with 6.5 (P = 0.005) and 6.4 (P = 0.006) fold higher prevalence, 
respectively, when compared to the lowest TM and OM exposure groups (Fig. 2 and Table 
3). Although not significant, an exposure-response was observed for sneeze and throat 
symptoms as well. Workers in the highest TM mixture exposure group had 3.0 (P = 0.14) 
and 2.0 (P = 0.38) fold higher prevalence of sneeze and burning, dry, or sore throat, 
respectively, when compared to the lowest exposure group (Fig. 2). Workers in the highest 
OM mixture exposure group had 5.3 (P = 0.11) and 1.4 (P = 0.6) fold higher prevalence of 
sneeze and burning throat, respectively, when compared to the lowest exposure group. The 
number of workers that reported lower airway symptoms during their shift was too small to 
calculate prevalence ratios using the GENMOD log-binomial procedure in SAS.
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Chronic upper and lower airway symptoms
Chronic nasal problems and watery eyes in the last 12 months were reported by 57.1% and 
51.4% of participants in the extended questionnaire (n = 35; Table 2). Chronic lower airway 
symptoms of usual cough, shortness of breath when hurrying on level ground, wheeze in the 
previous 12 months, and awaken from chest tightness in the previous 12 months were 
reported by 5.7%, 22.9%, 14.3%, and 17.1% of the 35 extended questionnaire participants, 
respectively.
No single individual chemical constituent in the TM of HP, PAA, and AA was consistently 
associated with the chronic upper and lower airway symptoms (Supplementary Table 3, 
available at Annals of Work Exposures and Health online). The highest TM and OM 
exposure group had 3.1 and 3.7 fold higher prevalence of shortness of breath on level ground 
when compared to the lowest OM and TM exposure groups, respectively (Table 3). 
Shortness of breath on level ground was significantly associated with increased TM (P = 
0.026) and OM exposure (P = 0.017). Prevalence of wheeze in the last 12 months was 2.3–
2.8 fold higher in the highest TM and OM exposure groups, when compared to the lowest 
exposure group (Table 3). Age, smoking status, gender, and use of other cleaning products 
containing asthmagens were not significantly associated with chronic eye, upper airway, or 
lower airway symptoms reported in the extended questionnaire and were not included in the 
analyses presented here.
Discussion
Few studies have evaluated occupational exposure to HP, PAA, and AA and health outcomes 
in a health care setting (Cristofari-Marquand et al., 2007; Casey et al., 2017). In this study, 
work-related acute eye and nasal symptoms and chronic airway symptoms were reported by 
hospital workers using a sporicidal product containing HP, PAA, and AA. We observed 
significant associations between work-related acute eye and nasal symptoms and chronic 
airway symptoms and increases in exposure to the total exposure mixture (TM), as well as 
when AA was not included in the exposure mixture variable (OM). The highest TM (HP + 
PAA + AA) and OM (HP + PAA) exposure groups were both associated with a 3.5 and 6.4–
6.5 fold increase in acute nasal and eye irritation, respectively (Fig. 2). Our observation of 
increases in acute nasal and eye irritation was not surprising given that HP and AA have 
OELs based on eye, upper respiratory tract, and skin irritation in exposed subjects, however, 
no full-shift exposures measured in our study exceeded the OELs of 1 ppm for HP or 10 
ppm for AA, respectively. Further, increases in exposure to the TM and OM were also 
significantly associated with chronic shortness of breath on level ground. The highest TM 
and OM exposure groups had 3.1- and 3.7-fold higher prevalence of shortness of breath, and 
2.3- and 2.8-fold higher prevalence of wheeze in the last 12 months, when compared to the 
lowest TM and OM exposure groups, respectively, albeit these increases were not significant 
(Table 3).
HP and PAA are both strong oxidants and are associated with biological effects at much 
lower concentrations than AA, as evidenced by the lower established and suggested 
exposure limits for HP and PAA (Pacenti et al., 2010; ACGIH 2016). Previous work by 
Gagnaire et al. observed responses in mice exposed to either HP, PAA, or AA and noted that 
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the irritant potency of PA was the strongest of the three chemicals. The authors noted that 
PAA’s irritant potency was similar to other powerful irritants to include formaldehyde, 
allylic compounds, chloropicrine, and chlorine or nitrogen trichloride (Gagnaire et al., 
2002). Gagnaire et al. also highlighted that HP had an irritant potency similar to strongly 
irritating amines to include propylamine, n-butylamine, or n-pentyl amine (Gagnaire et al., 
2002). Because HP and PAA are strong irritants and oxidants, exposure to the mixture of HP 
and PAA vapors may have contributed to the acute eye and upper airway irritation 
symptoms, as well as shortness of breath, reported by hospital cleaning workers using 
Product A.
We note that although ACGIH established a 15-min exposure TLV of 0.4 ppm for PAA, no 
full-shift TWA OEL currently exists in the United States for exposure to PAA. Multiple 
researchers have proposed a TWA OEL of 0.2 ppm for PAA based on observed respiratory 
irritation in rodents and humans (Gagnaire et al., 2002; Pacenti et al., 2010; Pechacek et al., 
2015). The Institut National de Recherche et Sècuritè in France also proposed a full-shift 
OEL for PAA of 0.2 ppm (Pacenti et al., 2010). Air concentrations of PAA observed in our 
study were well below the suggested TWA OEL for PAA. Maximum levels of PAA in our 
study approached one-quarter the proposed 0.2 ppm TWA OEL (Gagnaire et al., 2002; 
Pacenti et al., 2010; Pechacek et al., 2015). We observed significant positive associations 
with eye and airway irritation symptoms at exposures below the existing or suggested 
exposure limits for HP or PAA, respectively. Because HP and PAA are both strong oxidants 
and may have a similar mode of action on the respiratory tract, we consider our approach of 
using the ACGIH additive mixture formula to sum concentrations of HP and PAA, 
normalized to their respective established and suggested OELs, to be a potentially 
biologically relevant exposure metric. We observed significant positive associations with eye 
and airway symptoms at additive mixture exposure levels (OM) that were below the ACGIH 
additive mixture equation TLV of one (ACGIH, 2016).
A 2007 case study reported occupational asthma in two nurses exposed daily to HP, PAA, 
and AA vapors when sterilizing endoscopy equipment and documented work-related 
rhinorrhea, conjunctivitis, cough, wheeze, and shortness of breath (Cristofari-Marquand et 
al., 2007). Work-related symptoms were reported by each worker as beginning after 5 
months or 3 years of daily exposure to HP, PAA, and AA vapors. Although Cristofari-
Marquand et al. did not quantify exposure to HP and PAA, they used AA area air 
concentrations as a surrogate for exposure to HP and PAA. They reported that the highest 
area AA exposures measured ranged from 1.6 to 9.7 ppm, and in the highest case, 
approached the NIOSH REL and OSHA PEL of 10 ppm for AA. The maximum AA 
concentrations observed in our study here were 8- to 18-fold less than maximum area AA 
concentrations reported in the case study. However, we observed increases in many of the 
same eye, upper airway, and lower airways symptoms reported by Christofari-Marquand et 
al., despite lower air concentrations measured in our survey. No full-shift TWA samples in 
our survey exceeded the NIOSH REL or OSHA PEL of 1 ppm for HP or 10 ppm for AA 
(Fig. 1). Maximum HP and AA levels observed in our study were approximately one-half 
and one-twentieth of the NIOSH REL and OSHA PEL of 1 ppm for HP, and 10 ppm for AA, 
respectively.
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Cleaning staff are often exposed to a complex mixture of irritants and sensitizers 
(Bessonneau et al., 2013; Gonzalez et al., 2014; Melchior Gerster et al., 2014). Exposure to 
cleaning agents with sporicidal activity such as glutaraldehyde, formaldehyde, and chlorine 
compounds is associated with adverse health outcomes which include upper airway irritation 
and irritant or sensitizer induced asthma (AOEC, 2015). The Association of Occupational 
and Environmental Clinicians (AOEC) recently listed the mixture of HP and PAA as an 
asthmagen. However, the mechanism by which HP and PAA induce asthma has yet to be 
characterized (Rideout et al., 2005; Cristofari-Marquand et al., 2007; AOEC, 2015). 
Cristofari-Marquand et al. (2007) hypothesize that both the irritant and sensitizer pathways 
to asthma may be possible after exposure to HP and PAA. Regardless of the mechanism, the 
prognosis for workers who develop occupational asthma and continue to be exposed to the 
irritant or sensitizing agent is poor (Ortega et al., 2002). Additionally, we note that when 
OELs do exist, the exposure limits may not be protective for a worker that has become 
sensitized. Previous studies highlight that sensitizer induced asthma may have greater socio-
economic consequences for a worker that develops occupational asthma beyond the health 
effects alone. Vandenplas et al. (2003) highlight that 25–38% of workers diagnosed with 
occupational asthma will experience prolonged work disruption and 42–78% will report a 
substantial loss in income. For cleaning staff that develop asthma related to exposure to HP 
and peroxy acids, removal from cleaning duties that require the use of sporicidal agents may 
be warranted; however, these decisions should be discussed carefully with their physician 
(Mapp et al., 2005; Smith and Bernstein, 2009).
The Healthcare Infection Control Practices Advisory Committee (HICPAC) provides 
recommendations for when and where sterilization with sporicides, versus disinfection with 
high- and low-level disinfectants, should occur in health care facilities (Rutala and Weber, 
2008). HICPAC states that at higher concentrations, HP, and PAA mixtures are used as high-
level disinfectants for semicritical items that come into contact with mucus membranes or 
non-intact skin like respiratory therapy and anesthesia equipment, and some endoscopes 
(Rutala and Weber, 2008). In the 2007 case study, the nurses who developed work-related 
rhinorrhea, conjunctivitis, cough, wheeze, and shortness of breath were exposed to HP, PAA, 
and AA vapors while sterilizing endoscopy equipment (Cristofari-Marquand et al., 2007). 
Recently, the mixture of HP and PAA at lower concentrations has shown promise as a novel 
sporicidal agent that can be used on a wide variety of surfaces (Deshpande et al., 2016). We 
note that the at-use concentrations for HP and PAA in Product A are lower than 
concentrations of HP and PAA used for high-level disinfection. However, we observed acute 
symptoms in cleaning staff exposed to HP, PAA, and AA vapors even with a lower at-use 
concentration of HP and PAA. We observed cleaning staff using the sporicidal agent, 
Product A, on surfaces throughout the hospital, including surfaces in patient rooms and in 
non-patient care areas. Substitution with a low-level disinfectant for routine cleaning of 
surfaces in non-patient areas is one option for reducing exposures, though this may not be 
possible for surfaces in areas with isolation precautions in place. Additionally, substitution 
with another low-level disinfectant such as phenolic, iodophors, alcohols, or chlorine 
compounds may also cause upper airway irritation and irritant or sensitizer induced asthma 
in some workers. A combination of engineering controls such as increased ventilation, 
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administrative controls such as removal from cleaning duties, and PPE controls can be used 
in areas where substitution with less hazardous chemicals may not be possible.
Our study was small and this may have affected our ability to detect significant associations. 
The small sample size impaired our ability to calculate prevalence ratios for the acute lower 
airway symptoms. Furthermore, our health assessment was limited to symptoms; we did not 
include objective health measurements such as lung function testing. However, we used 
questions from standardized instruments whenever possible. In particular, we defined 
asthma-like symptoms based on a set of questions that had been validated by reference to 
clinical diagnosis of asthma (Grassi et al., 2003). Nonetheless, we were unable to assess 
potential limitations associated with self-report such as recall bias. We did not assess the 
severity of acute symptoms reported by cleaning staff in our post-shift survey. Future studies 
that utilize a survey of acute symptoms could be designed to include questions about the 
severity and duration of acute symptoms experienced by the workers during their shift as 
well as objective health measurements. Another limitation of our study is that we only 
collected full-shift TWA samples for the three chemical constituents, HP, PAA, and AA, 
found in Product A. Sampling and analytical limitations hindered our ability to assess short-
term exposures and compare short-term exposures with the established short-term exposure 
limits established by the ACGIH. Additionally, we did not sample for other irritants or 
sensitizers. However, we were able to observe and record cleaning workers’ use of other 
asthmagen-containing products, and did not find any significant associations between 
symptoms and use of products containing bleach, ethanolamine, quaternary ammonium 
compounds, or any combination of the three other asthmagens observed in use by cleaning 
staff as they performed their regular cleaning duties.
Occupational exposure to PAA has been largely undocumented due to previous sampling 
and analytical method limitations. The sampling method we used to collect HP and PAA 
relies upon a sampling train that simultaneously collects HP and PAA (Hecht et al., 2004). 
Manning et al. (2016) observed that because HP and PAA share similar reactivity, almost 
any reagent that reacts with HP will react with PAA, and they noted the potential for some 
PAA to be collected on the quartz filter used for collection and analysis of HP. The results 
presented by Manning et al. (2016) suggest that given the range of PAA concentrations 
measured in our study (1.1–48 ppb), the actual concentrations of PAA could have been twice 
as high as what we measured, and some of the PAA may have been misclassified as HP on 
the quartz filter. We attempted to address this potential limitation by summing the values of 
HP and PAA to generate the OM and TM exposure variables used for all analyses.
Our study here measured occupational exposure to HP, PAA, and AA in a hospital facility; 
however, workers may be exposed to HP, PAA, and AA in occupational settings outside of 
health care settings such as childcare, food service, agricultural, and food production 
industries (Straus and Meinelt 2009). Further study is warranted to develop an improved 
sampling method for HP and PAA collection and analysis, and characterize the potential 
health effects from occupational exposure to HP, PAA, and AA across a wide range of 
possible exposures in different occupational settings.
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Conclusions
Hospital workers using a sporicidal product containing HP, PAA, and AA reported work-
related acute eye and upper airway symptoms, as well as chronic airway symptoms at low 
levels of measured exposures. Increased exposure to the mixture of HP, PAA, and AA was 
significantly associated with increases in work-related acute nasal irritation and eye 
irritation. Increased exposure to the oxidant mixture of HP and PAA was also significantly 
associated with work-related acute nasal and eye irritation as well as chronic shortness of 
breath. All full-shift TWA air samples for HP and AA were below established US OELs. To 
date, no full-shift TWA OEL for PAA has been established in the United States, although a 
TWA OEL of 0.2 ppm for PAA has been proposed by several groups. All TWA air samples 
for PAA were below the proposed TWA OEL of 0.2 ppm for PAA. Because both HP and 
PAA are strong oxidants, the mixture of HP and PAA potentially contributed to the airway 
symptoms reported by cleaning staff, at the low levels of measured exposures. Our 
observations of respiratory symptoms in hospital workers using a sporicidal product 
containing HP, PAA, and AA, indicate a need for engineering, administrative, and/or PPE 
controls to reduce exposure. Follow-up monitoring of respiratory and eye symptoms in 
hospital cleaning staff using cleaning products containing HP, PAA, and AA, can be used to 
evaluate the effectiveness of controls used to reduce exposure.
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Figure 1. 
Box-whisker plots of time-weighted average (TWA) concentrations for hydrogen peroxide 
(HP), peracetic acid (PAA), and acetic acid (AA). Outliers are indicated by single points. 
Each box shows the 25th to 75th percentile range for HP, PAA, and AA, respectively, with 
the median value marked as the horizontal line inside the box. The NIOSH REL and OSHA 
PEL is 1000 ppb for HP and 10 000 ppb for AA.
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Figure 2. 
Prevalence ratios and 95% confidence intervals for eye and upper airway symptoms reported 
during work-shift in the medium and high total mixture and oxidant mixture exposure 
groups. *P < 0.05.
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Table 3
Acute and chronic symptom prevalence ratios, by total mixture and oxidant mixture exposure groupa
Acute symptom
TM prevalence ratio (95% CI) OM prevalence ratio (95% CI)
Medium High Medium High
 Nasal irritationbc 1.88 (0.70–5.05) 3.50 (1.47–8.34) 2.00 (0.76–5.26) 3.47 (1.45–8.29)
 Eye irritationbc 3.29 (0.80–13.56) 6.50 (1.74–24.27) 3.56 (0.88–14.35) 6.40 (1.71–23.98)
 Sneeze 1.41 (0.27–7.38) 3.00 (0.71–12.69) 4.44 (0.58–34.14) 5.33 (0.70–40.54)
 Burning, dry, sore throat 1.41 (0.27–7.38) 2.00 (0.42–9.42) 0.59 (0.11–3.11) 1.42 (0.38–5.33)
 Cough — — — —
 Wheeze — — — —
 Chest tightness — — — —
 Shortness of breath — — — —
 Difficulty breathing — — — —
 Dizziness — — — —
Chronic symptom Medium High Medium High
 Nasal problems, previous 12 months 1.25 (0.49–3.22) 1.92 (0.85–4.35) 1.10 (0.47–2.60) 1.65 (0.80–3.41)
 Watery eyes, previous 12 months 1.04 (0.38–2.87) 1.73 (0.75–4.01) 0.92 (0.36–2.33) 1.47 (0.69–3.14)
 Usual cough — 0.77 (0.05–10.84) — 0.92 (0.06–12.95)
 Shortness of Breath on level groundc 2.50 (0.31–20.45) 3.08 (0.40–23.44) 2.75 (0.33–22.69) 3.67 (0.48–28.00)
 Wheeze, previous 12 months 0.83 (0.06–11.70) 2.31 (0.28–18.99) 0.92 (0.06–12.95) 2.75 (0.33–22.69)
 Awaken from chest tightness, previous 12 months 0.42 (0.04–3.95) 1.15 (0.24–5.65) 0.31 (0.04–2.52) 0.61 (0.12–3.00)
 Asthma medication use — 1.54 (0.16–14.66) — 1.83 (0.19–17.51)
 Asthma-like symptoms 0.56 (0.11–2.70) 1.28 (0.40–4.13) 0.46 (0.10–2.03) 0.92 (0.30–2.81)
The symbol ‘—’ denotes the number of workers that reported symptoms was too small to calculate prevalence ratios using the GENMOD log-
binomial procedure in SAS.
aCompared to those in the low exposure group.
b
Indicates symptoms significantly positively associated with increased exposure to the total mixture of HP, PAA, and AA (P < 0.05).
c
Indicates symptoms significantly positively associated with increased exposure to the oxidant mixture of HP and PAA (P < 0.05).
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